CME Presentations

Pediatric Epilepsies - Part 2


Presentations


Speakers

  • Linda Laux, MD

    Linda Laux, MD

    Linda Laux, MD

    Pediatric Epileptologist

    Linda C. Laux, MD, is the medical director of the Comprehensive Epilepsy Center at Ann & Robert H. Lurie Children’s Hospital of Chicago and associate professor of pediatrics at Northwestern University Feinberg School of Medicine. Dr Laux’s research is centered on children with Dravet syndrome, which has allowed her to evaluate over 200 children with Dravet syndrome and to speak at national conferences throughout the United States. She is the board chair of the Medical Advisory Board for the Dravet Syndrome Foundation (DSF) and has participated in every biennial parent and professional symposium on Dravet syndrome since the inception in 2006. Dr Laux received her medical degree from St. Louis University School of Medicine.
  • Elaine C. Wirrell, MD, FRCPC

    Elaine C. Wirrell, MD, FRCPC

    Elaine C. Wirrell, MD, FRCPC

    Professor of Child and Adolescent Neurology

    Elaine C. Wirrell, MD, FRCPC, is professor of child and adolescent neurology, and consultant and chief of Pediatric Epilepsy at Mayo Clinic in Rochester, Minnesota. Dr Wirrell’s research focuses on epidemiology and the treatment of pediatric epilepsy, as well as comorbidities. Her research has led to 173 peer-reviewed articles and 19 book chapters. Dr Wirrell is chair of the AES Pediatric Content Committee and of the ICNA Research Committee, and co-chair of the ILAE Nosology and Definitions Committee Member: Pediatric Psychiatry Committee. She is a member of the Fellow of the Royal College of Physicians & Surgeons of Canada, the Minnesota Board of Medical Practice, and the American Epilepsy Society. Dr Wirrell received her medical degree from University of British Columbia in Vancouver.

CME Information

Dravet Syndrome: Opportunities for Improvement in Diagnosis and Management


Global LogoPQH Logo

EDUCATIONAL OBJECTIVES

After completing this activity, the participant should be better able to:

  • Describe clinical features of Dravet syndrome to facilitate an early diagnosis
  • Select appropriate treatments with proven efficacy and safety in Dravet syndrome
  • Discuss emerging treatment options for Dravet syndrome
This activity is jointly provided by Global Education Group and PlatformQ Health Education, LLC.

ACKNOWLEDGEMENT

This activity is supported by an educational grant from Zogenix, Inc.

DATE OF RELEASE/EXPIRATION

May 12, 2020 – July 31, 2021

TARGET AUDIENCE

The educational design of this activity addresses the needs of neurologists, pediatric neurologists, pediatricians and other health care professionals (including physicians, physicians-in-training, nurses, physician assistants, nurse practitioners, pharmacists, etc.) involved and/or interested in the management of patients with severe forms of pediatric intractable epilepsy.

STATEMENT OF NEED/PROGRAM OVERVIEW

Experts consider Dravet syndrome among the most challenging epilepsy syndromes to manage. Dravet syndrome is a severe, intractable and difficult-to-manage epileptic syndrome, characterized by marked and prolonged multiple seizure types, with intellectual disability and comorbid behavioral disorders.

In this continuing medical education activity, the expert faculty will discuss the importance of early diagnosis of Dravet syndrome, at the time when effective treatments might have the best chance of altering the clinical course of the disease. Importantly, newer treatments have been evaluated in randomized trials for Dravet syndrome which can potentially increase the number of treatment options for patients with these difficult-to-manage conditions. During this lively discussion, the goals are to enhance the knowledge related to diagnosis, management, and overall care of Dravet syndrome while improving health care providers’ (HCPs) competence in treating these conditions and managing the many nonclinical issues patients and caregivers will face. This activity is the second in a series of four on diagnosis and management of Dravet and Lennox Gastaut syndromes, and focuses on opportunities for improvement in diagnosis and management of Dravet syndrome.

PHYSICIAN ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and PlatformQ Health Education, LLC. Global is accredited by the ACCME to provide continuing medical education for physicians.

PHYSICIAN CREDIT DESIGNATION

Global Education Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING CONTINUING EDUCATION

Global Education Group is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 1.0 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

PHARMACIST ACCREDITATION STATEMENT

ACPE Logo

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

CREDIT DESIGNATION

Global Education Group designates this continuing education activity for 1.0 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-9999-20-046-H01-P)
This is a knowledge-based activity.

TERM OF OFFERING

This activity was released on May 12, 2020 and is valid for 14 months. Requests for credit must be made no later than July 31, 2021.

ESTIMATED TIME TO COMPLETE

This activity should take approximately 1 hour to complete.

INSTRUCTIONS TO RECEIVE CREDIT

In order to receive credit for this activity, the participant must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credits™, participants must receive a minimum score of 70% on the post-test. For pharmacist/ACPE learners, please check the CPE monitor for your CE credit within 60 days of the activity.

HARDWARE/SOFTWARE REQUIREMENTS

Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FEE INFORMATION & REFUND/CANCELLATION POLICY

There is no fee for this educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Faculty or Presenter Reported Financial Relationship
Linda Laux, MD
Pediatric Epileptologist
Director, Lurie Children’s Epilepsy Center
Ann & Robert H. Lurie Children’s Hospital of Chicago
Associate Professor
Northwestern University Feinberg School of Medicine
Advisory Board: Biocodex
Elaine C. Wirrell, MD
Professor of Child and Adolescent Neurology
Consultant and Chief of Pediatric Epilepsy
Mayo Clinic, Rochester, MN
Consultant/Independent Contractor: Biocodex


The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Name of Planner or Manager Reported Financial Relationship
Ashley Marostica, RN, MSN Nothing to disclose
Lindsay Borvansky Nothing to disclose
Andrea Funk Nothing to disclose
Liddy Knight Nothing to disclose
Ashley Cann Nothing to disclose
Carole Drexel Nothing to disclose
Alissa Yost Nothing to disclose

DISCLOSURE OF UNLABELED USE

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and PlatformQ Health Education, LLC. do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CONTACT INFORMATION

Accreditation Support:
For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Technical Support:
For any technical issues or issues with your CME Certificate, please contact NeruoSeriesLive at 877-394-1306 or at Support@NeuroSeriesLive.com.